Thirty-three states, the District of Columbia, and Puerto Rico will participate in CMS’ voluntary Cell and Gene Therapy (CGT) ...

Intranasal fentanyl is a feasible, safe, and effective option for managing acute pain episodes in adults with sickle cell ...

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

Sickle cell disease can lead to a severe complication known as acute chest syndrome (ACS), but the underlying mechanisms are not well understood. A new study by Mass General Brigham investigators ...

The misshapen cells tend to block blood flow in the vessels, leading to frequent pain episodes, infections, and damage to organs.

Sickle cell disease (SCD) is a prevalent and complex inherited pain disorder that can manifest as acute vaso-occlusive crises (VOC) and/or chronic pain. Despite their known risks, opioids are often ...

Are they effective in managing severe acute pain crises and/or reducing their frequency? What treatments or interventions used for acute sickle cell crises are equivalent to parenteral opioid ...

Discover effective strategies to minimize sickle cell pain crises and avoid hospitalizations. Leading hematologists share practical approaches for better disease management.

Accurate pain reporting in sickle cell disease is critical to effective pain assessment and management, but accuracy depends on patient comprehension of forms.

The webinar will focus on pain management in sickle cell disease (SCD), with special attention to the following questions: When and how often are parenteral opioid pain medications used to manage SCD ...